|
|
|
Company
Name |
Short
Summary |
| Achillion Pharmaceuticals |
Achillion Pharmaceuticals is focused on the development of small molecule treatments for HCV, resistant bacterial infections, and HIV. |
| Artificial Cell Technologies |
Artificial Cell Technologies is focused of vaccine development utilizing a technology platform of ultra-thin multilayer nanofilms composed of custom-designed polypeptides. |
| Axerion Therapeutics |
Axerion Therapeutics is focused on the research and development of therapeutics for neurological diseases and injuries. |
| Covidien |
Covidien is focused on the devevlopment and commercialization of clinical and home healthcare products. |
| Ikonisys |
Ikonisys is focused on the development and commercialization of its CellOptics® platform for rare cell detection. |
| Kolltan Pharmaceuticals |
Kolltan Pharmaceuticals is focused on the development of monoclonal antibody and small-molecule drugs targeting receptor tyrosine kinases. |
| Optherion |
Optherion is focused on developing diagnostics and therapeutics for early-stage age-related macular degeneration, dense deposit disease, membranoproliferative glomerulonephritis, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. |
| Rib-X Pharmaceuticals |
Rib-X Pharmaceuticals is focused on the research and development of broad spectrum antibiotics. |
| Vion
Pharmaceuticals |
Vion
Pharmaceuticals, Inc. is a biopharmaceutical company
engaged in the discovery, development and commercialization
of cancer therapeutics. |
